Survival of patients with intermediate stage hepatocellular carcinoma treated with superselective transarterial chemoembolization using doxorubicin-loaded DC Bead under cone-beam computed tomography control
By:
References
- El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology 2007; 32: 2557-76. - Suk Oh J, Jong Chun H, Gil Choi B, Giu Lee H. Transarterial chemoembolization with drug-eluting bead in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response.
J Vasc Interv Radiol 2013; 24: 483-9. - Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival.
Hepatology 2003; 37: 429-42. - Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
Hepatology 2002; 35: 1164-71. - European Association For The Study Of The Liver and European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.
J Hepatol 2012; 56: 908-43. - Burrel M, Reig M, Forner A, Barrufet M, de Lope CR, Tremosini S, et al. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.
J Hepatol 2012; 56: 1330-5. - Kim GM, Kim HC, Chung JW, Lee IJ, Kim HM, Jae HJ, et al. Chemoembolization for hepatocellular carcinoma supplied exclusively by the hepatic falciform artery.
Cardiovasc Intervent Radiol 2012; 35: 845-51. - Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.
Cardiovasc Intervent Radiol 2010; 33: 41-52. - Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of Hepatocellular Carcinoma.
Semin Intervent Radiol 2013; 30: 3-11. - Malagari K, Pomoni M, Kelekis A, Pomoni A, Dourakis S, Spyridopoulos T, et al. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
Cardiovasc Intervent Radiol 2010; 33: 541-51. - Golfieri R, Cappelli A, Cucchetti A, Piscaglia F, Carpenzano M, Peri E, et al. Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (< 5 cm) hepatocellular carcinomas.
Hepatology 2011; 53: 1580-9. - Jin B, Wang D, Lewandowski RJ, Riaz A, Ryu RK, Sato KT, et al. Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma.
Am J Roentgenol 2011; 196: 919-28. - Takayasu K. Superselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspective.
Oncology 2011; 81(Suppl 1): 105-10. - Iwazawa J, Ohue S, Mitani T, Abe H, Hashimoto N, Hamuro M, et al. Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography.
AJR Am J Roentgenol 2009; 192: 1057-63. - Higashihara H, Osuga K, Onishi H, Nakamoto A, Tsuboyama T, Maeda N, et al. Diagnostic accuracy of C-arm CT during selective transcatheter angiography for hepatocellular carcinoma: comparison with intravenous contrast-enhanced, biphasic, dynamic MDCT.
Eur Radiol 2012; 22: 872-9. - Loffroy R, Lin M, Yenokyan G, Rao PP, Bhagat N, Noordhoek N, et al. Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?
Radiology 2013; 266: 636-48. - Floridi C, Radaelli A, Abi-Jaoudeh N, et al. C-arm cone-beam computed tomography in interventional oncology: technical aspects and clinical applications.
Radiol Med 2014; 119: 521-32. - Tacher V, Radaelli A, Lin M, Geschwind JF. How I Do It: Cone-Beam CT during Transarterial Chemoembolization for Liver Cancer.
Radiology 2015; 274: 320-34. - Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Sugimori N, Igarashi S, et al. Usefulness of cone-beam computed tomography during ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinomas that cannot be demonstrated on angiography.
Cardiovasc Intervent Radiol 2009; 32: 255-64. - Miyayama S, Yamashiro M, Hashimoto M, Hashimoto N, Ikuno M, Okumura K, et al. Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤ 6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography.
Cardiovasc Intervent Radiol 2014; 37: 388-95. - Iwazawa J, Ohue S, Hashimoto N, Muramoto O, Mitani T. Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma.
Eur J Radiol 2012; 81: 3985-92. - Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
Semin Liver Dis 2010; 30: 52-60. - Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).
J Surg Oncol 2010; 101: 476-80. - Boatta E, Corona M, Cannavale A, Fanelli F, Cirelli C, de Medici L. Endovascular treatment of hepatocellular carcinoma with drug eluting microparticles (DC-Beads): CT evaluation of response to the treatment.
Indian J Radiol Imaging 2013; 23: 126-33. - Georgiades C, Geschwind JF, Harrison N, Hines-Peralta A, Liapi E, Hong K, et al. Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment?
Radiology 2012; 265: 115-23. - Lencioni R, Chen XP, Dagher L, Venook AP. Treatment of intermediate/ advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
Oncologist 2010; 4(Suppl 15): 42-52. - Cabibbo G, Genco C, Di Marco V, Barbara M, Enea M, Parisi P, et al. Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation.
Aliment Pharmacol Ther 2011; 34: 196-204. - Huang K, Zhou Q, Wang R, Cheng D, Ma Y. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
J Gastroenterol Hepatol 2014; 29: 920-5. - Malagari K, Pomoni M, Moschouris H, Bouma E, Koskinas J, Stefaniotou A, et al. Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis.
Cardiovasc Intervent Radiol 2012; 35: 1119-28. - Kim BK, Kim SU, Kim KA, Chung YE, Kim MJ, Park MS, et al. Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma.
J Hepatol 2015; 62: 1304-10. - Zach V, Rapaport B, Yoo JY, Goldfeder L, Weinberger J. Multiple ischemic strokes after transcatheter arterial chemoembolization for hepatocellular carcinoma with a radiographic and pathological correlate.
J Stroke Cerebrovasc Dis 2012; 21: 217-24. - Loffroy R, Favelier S, Cherblanc V, Estivalet L. C-arm dual-phase cone-beam CT: a revolutionary real-time imaging modality to assess drug-eluting beads TACE success in liver cancer patients.
Quant Imaging Med Surg 2013; 3: 196-9. - Kim HC, Chung JW, Lee W, Jae HJ, Park JH. Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization.
Radiographics 2005; 1(Suppl 25): 25-39. - Miyayama S, Matsui O, Taki K, Minami T, Ryu Y, Ito C, et al. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization.
Cardiovasc Intervent Radiol 2006; 29: 39-48.
Language: English
Page range: 418 - 426
Submitted on: Jun 10, 2015
Accepted on: Aug 19, 2015
Published on: Nov 10, 2016
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2016 Peter Popovic, Borut Stabuc, Rado Jansa, Manca Garbajs, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.